Literature DB >> 9890636

The role of reactive oxygen species in triggering proliferation and IL-2 secretion in T cells.

S Tatla1, V Woodhead, J C Foreman, B M Chain.   

Abstract

This paper examines the hypothesis that reactive oxygen species (ROS) play an important role as second messengers in T cell activation. Activation of T cells with phorbol ester in combination with either calcium ionophore, or anti-CD3 antibody results in a large rapid flux of ROS activity. In contrast, co-stimulation with CD28 does not enhance ROS activity. The ROS signal was sensitive to ascorbic acid, desferrioxamine and dimethyl sulfoxide, suggesting that the major active species being generated was the hydroxyl radical, probably by iron-catalyzed decomposition of hydrogen peroxide. The generation of ROS in T cells was regulated by an accessory population within the peripheral blood. An anti-CD2 antibody induced a strong ROS flux, suggesting that the CD2/LFA-3 interaction may be important in this regulation. T cell activation was inhibited by the same panel of anti-oxidants as ROS generation, but much higher concentrations were required for inhibition of proliferation and IL-2 release than those required to block ROS generation. These data imply that ROS are not obligate second messengers for initiation of T cell activation. The results are compatible, however, with a role for activation-dependent T cell ROS generation in modulating the overall T cell response via autocrine and paracrine signalling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890636     DOI: 10.1016/s0891-5849(98)00133-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

Review 1.  Whole tumor antigen vaccines.

Authors:  Cheryl Lai-Lai Chiang; Fabian Benencia; George Coukos
Journal:  Semin Immunol       Date:  2010-03-30       Impact factor: 11.130

2.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

3.  Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease.

Authors:  Dave R Dobis; Richard T Sawyer; May M Gillespie; Jie Huang; Lee S Newman; Lisa A Maier; Brian J Day
Journal:  Am J Respir Crit Care Med       Date:  2008-01-24       Impact factor: 21.405

4.  A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.

Authors:  Matthew S J Mangan; Catherina H Bird; Dion Kaiserman; Anthony Y Matthews; Corinne Hitchen; David L Steer; Philip E Thompson; Phillip I Bird
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

5.  Oxidative stress impairs intracellular events involved in antigen processing and presentation to T cells.

Authors:  Olivier Preynat-Seauve; Sylvia Coudurier; Alain Favier; Patrice-Noël Marche; Christian Villiers
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

6.  Signal transduction pathways in chronic inflammatory autoimmune disease: small GTPases.

Authors:  Kris A Reedquist; Paul P Tak
Journal:  Open Rheumatol J       Date:  2012-09-07

7.  A genetic analysis of nitric oxide-mediated signaling during chronological aging in the yeast.

Authors:  Anna Lewinska; Ewa Macierzynska; Agnieszka Grzelak; Grzegorz Bartosz
Journal:  Biogerontology       Date:  2011-03-19       Impact factor: 4.277

8.  Identification of NCF2/p67phox as a novel p53 target gene.

Authors:  Dafne Italiano; Anna Maria Lena; Gerry Melino; Eleonora Candi
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

9.  ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages.

Authors:  Yan Zhang; Swati Choksi; Kun Chen; Yelena Pobezinskaya; Ilona Linnoila; Zheng-Gang Liu
Journal:  Cell Res       Date:  2013-06-11       Impact factor: 25.617

10.  A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.

Authors:  Lana E Kandalaft; Cheryl L Chiang; Janos Tanyi; Greg Motz; Klara Balint; Rosemarie Mick; George Coukos
Journal:  J Transl Med       Date:  2013-06-18       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.